Barbara Klencke

CIK 1647647 · Chief Medical Officer · last filed 2026-05-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$306.4K

Companies

6

Total Filings

34

Lifetime Open-Market Net

$322.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TCRX Director 70,000 $0.91 $63.8K $108.0K 8 2026-05-22
ALXO Chief Medical Officer $1.58 $0 4 2026-04-17
XNCR Director 19,672 $12.33 $242.6K $0 3 2025-06-16
eFFECTOR Therapeutics, Inc. (EFTRW) Delisted Director $0.00 $0 6 2024-06-13
Sierra Oncology, Inc. (SRRA) Delisted Chief Medical Officer 0 $54.99 $0 $214.1K 11 2022-07-01
Sierra Oncology, Inc. (DNAI) Delisted Chief Development Officer $0 2 2016-10-04

Recent Filings · Page 4 of 4

34 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-03-07 Sierra Oncology, Inc. (SRRA) Delisted Grant (A) $0 EDGAR
2017-03-08 Sierra Oncology, Inc. (SRRA) Delisted Grant (A) $0 EDGAR
2016-10-04 Sierra Oncology, Inc. (DNAI) Delisted Grant (A) $0 EDGAR
2016-03-10 Sierra Oncology, Inc. (DNAI) Delisted Grant (A) $0 EDGAR
Showing 3134 of 34
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.